Furthermore, we have recently identified a p53-MYC dual hub responsible for many of the BCR/ABL-induced changes in CML and illustrated the fact that targeting these two proteins eliminates the leukaemic stem cell.33 Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.